Intended for UK patients and members of the public
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintProduct Documentation
Last updated on this site: 03 Jan 2024
Description of update: To register an update to the ATC Code for the finished product from N03AX16 to N02BF02 following a WHO recommendation. Consequentially, section 5.1 of the SmPC has been updated.
SmPC Sections updated: 5.1 and 10.
No changes to PIL.
Last updated on this site: 27 Mar 2023
Description of update: To update sections 4.4, 4.8, 4.9 and 5.3 of the SmPC in line with reference product, Lyrica hard capsules updated with procedure outcome of EMEA/H/C/WS2168; MAH: Upjohn EESV, Netherlands, EMEA/H/C/WS2261; MAH: Upjohn EESV, Netherlands and EMEA/H/C/WS2293; MAH: Upjohn EESV, Netherlands. Consequently, the PIL has been updated.
PIL sections updated: 2, 4, 6.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintFor any further assistance, please get in touch.